Lawyer: Actavis owes no apology for seeking new Alzheimer's drug profits, critic 'dead wrong!'

April 14, 2015 12:54 AM

17 0

NEW YORK (AP) — A lawyer for the Irish manufacturer of an Alzheimer's drug urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.

Attorney Lisa Blatt told the 2nd U.S. Circuit Court of Appeals in Manhattan that Dublin-based Actavis PLC makes no apologies for maximizing its profits, though a December court ruling has already caused it to lose at least $200 million in sales and forced it to spend tens of millions of dollars in p...

Read more

To category page